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Changes of a sputum colour are believed to signal a bacterial infection of lower
airways. The study analyses the relation between sputum colour and cultivation in
all paediatric CF patients from South Moravia CF Centre in last 10 years.
944 sputum samples were analysed. Samples were obtained from 49 patients from
2000 to 2009 and cultivated. 382 samples had record of the sputum colour. Colours
were divided into the 5 most prevalent groups: clear, white, yellow, green and
brown. A correlation between the sputum colour and the cultivation of main CF
lung pathogens was tested with Chi-square test.
Results from 944 samples: negative 33.8%, Staphylococcus aureus 29.7%, Pseu-
domonas aeruginosa 11.2%, Haemophilus inﬂuenzae 7.3%, streptococci 7.3%,
Burkholderia cepacia type IV 2.4%, Stenotrophomonas maltophilia 1.6%, As-
pergillus 0.5%, Mycobacterium tuberculosis 0.001%, contamination 8.6%. Sputum
colours were: yellow 42%, clear 31%, green 14%, white 12%, brown 2%. Clear
sputum correlates with negative cultivation (p< 0.01), 79% of clear samples were
negative. White sputum is predominantly negative (55%), but without statistical
signiﬁcance. Yellow and green colour correlate with positive cultivation (p< 0.01).
Only 6% of yellow and green samples were negative. Yellow samples yield:
S. aureus 59%, P. aeruginosa 19%, H. inﬂuenzae 8%, B. cepacia 6%. Green sputum
presents S. aureus 38%, P. aeruginosa 33%, H. inﬂuenzae 13%, B. cepacia 10%.
Brown sputum yield: P. aeruginosa 43%, S. aureus 29%, B. cepacia 29%.
The study concludes that the clear sputum colour correlates with negative bacterial
yield. White sputum is not speciﬁc. Yellow and green colour highly suggest the
presence of S. aureus or P. aeruginosa. For B. cepacia green and brown is typical.
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Bacterial species recovered from respiratory samples of cystic ﬁbrosis (CF) patients
require different clinical management as they exhibit heterogeneous pathogenicity,
thus their precise identiﬁcation is important.
Objetive: We reassessed historical results obtained by WIDER (Fco. Soria Mel-
guizo, Spain) and by API 20 NE (bioMe´rieux, France) usingMT (MALDI BioTyper
2.0, Bruker Daltonik, Germany).
Methods: 266 isolates (65 Achromobacter spp., 56 Burkholderia spp., 52 Pseu-
domonas aeruginosa, 20 Stenotrophomonas maltophilia, 16 Acinetobacter spp.,
10 non-aeruginosa Pseudomonas, 8 Chryseobacterium spp., 7 Bordetella spp.,
4 Ralstonia spp. and 28 other non-fermenting Gram-negative rods) recovered
from sputum of CF patients (1994–2009) and stored at −80ºC were re-identiﬁed
using MT. Discrepancies were resolved with PCR of 16S rDNA and sequencing.
Results: 88% of isolates displayed identical identiﬁcation at genus level by
conventional methods and MT although it was only 68% at species level. Lack
of identiﬁcation (4.5%) with MT was ascribed to insufﬁcient database entries. All
P. aeruginosa were identiﬁed. B. cepacia complex (6) and Burkholderia gladioli (7),
misclassiﬁed by routine methods, were correctly identiﬁed by MT. Additionally,
Pandoraea pnomenusa (8) not previously identiﬁed by conventional methods in our
laboratory were correctly identiﬁed by MT.
Conclusions: MT is a versatile tool that improves rapid identiﬁcation of bacteria
including those with limited biochemical reactivity frequently misidentiﬁed by the
classical approach. Despite its accuracy, MT database needs to be enlarged mainly
with infrequent species recovered from CF patients.
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The Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa is a highly
transmissible and successful cystic ﬁbrosis (CF) pathogen and is associated with
increased morbidity and mortality. The strain is prevalent across the UK and has
been reported in North America. Recent sequencing of an LES isolate, LESB58,
revealed the presence of multiple mobile genetic elements including ﬁve prophages,
each of which can actively produce bacteriophages.
We have developed plaque assays for two of the novel phages and visualised them
using electron microscopy. Signature tagged mutagenesis (STM) of LESB58 using
a rat chronic lung infection model allowed identiﬁcation of mutants attenuated
in competitiveness. 162 mutants with reduced competitiveness in the model were
identiﬁed, of which 12 had mutations within mobile genetic elements. For these
12 mutants we found no signiﬁcant difference in production of exoproducts or
resistance to six antibiotics in comparison to the wild-type. Six of the 12 mutants
showed signiﬁcantly reduced phage production and ﬁve could not produce one of
the two novel phages. For some mutants growth characteristics in L-broth were
affected: a mutation in a phage Clp protease led to an increase in growth rate and
a mutation in a phage antitermination Q protein resulted in a dramatic reduction in
bacterial numbers during stationary phase.
Our ﬁndings suggest that mobile genetic elements contribute to the competitiveness
of the LES in vivo and that mutations in these regions affect both phage production
and growth characteristics.
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Two-component systems (TCSs) facilitate the adaptive response of bacteria to
environmental stimuli. TCSs have been shown to play a pivotal role in the infectious
process of many bacterial pathogens. As a result, TCS-deﬁcient strains have
been developed as live vaccines, whilst TCS-inhibitors are recognised as potential
antimicrobial agents. The cystic ﬁbrosis pathogens Pseudomonas aeruginosa and
Burkholderia cepacia complex (Bcc) both harbour an exceptionally large number
of TCSs. We aim to assess how the TCSs of both organisms contribute to virulence
and/or antimicrobial resistance.
Our studies of P. aeruginosa are currently focused on the previously characterized
PmrA/PmrB TCS, which is associated with resistance to colistin and related
antimicrobials. We have identiﬁed several polymorphisms within the PmrA/PmrB
proteins of colistin-resistant strains which may inﬂuence activity of the TCS and
thus confer colistin resistance. Ongoing studies will assess the wider impact of these
mutations on the organism’s virulence and inﬂammatory properties. In contrast
to the focused analysis on P. aeruginosa PmrA/PmrB, our studies of Bcc have
involved a genome-wide analysis of previously uncharacterized TCSs. To date, we
have constructed approximately 40 TCS-deﬁcient B. cenocepacia (K56-2) mutants
through targeted gene inactivation. Several of these TCS-deﬁcient strains exhibit
reduced virulence in the Galleria mellonella infection model and/or reduced bioﬁlm
formation. Future studies will aim to identify the genes that are regulated by these
virulence-associated TCSs and investigate the activity of TCS-inhibitors as novel
antimicrobials against these organisms.
